Introduction to NDC 00054-0319
The National Drug Code (NDC) 00054-0319 corresponds to Linezolid, a pharmaceutical product used primarily for treating bacterial infections. Linezolid is an oxazolidinone antibiotic that is effective against a range of Gram-positive bacteria, including those resistant to other antibiotics.
Drug Overview: Linezolid
Mechanism of Action and Uses
Linezolid works by inhibiting protein synthesis in bacteria, making it an effective treatment for infections such as pneumonia, skin infections, and certain types of bloodstream infections. It is available in various forms, including oral suspension, tablets, and intravenous solutions[5].
Market Demand
The demand for Linezolid is steady due to its efficacy in treating resistant bacterial infections. This demand is driven by the increasing incidence of antibiotic-resistant bacteria and the need for effective treatments.
Current Pricing Trends
Historical Price Data
As of the latest data, the price per unit of Linezolid 100 mg/5 ml suspension (NDC 00054-0319) has shown some fluctuations:
- December 2024: $1.95344 per ml
- November 2024: $1.69693 per ml
- October 2024: $1.86166 per ml
- September 2024: $1.86166 per ml
- August 2024: $1.82657 per ml[1].
Vendor Pricing
Different vendors may offer varying prices for the same product. For example, Nationwide Pharmaceutical LLC listed a price of $2.58380 per unit for a 150 ml count of Linezolid 100 mg/5 ml suspension[1].
Projected Price Inflation
Overall Pharmaceutical Market
According to Vizient's summer Pharmacy Market Outlook, the overall drug price inflation rate for 2025 is projected to be 3.81%. This projection is influenced by factors such as the expanding indications of previously approved medications and the introduction of high-cost cell and gene therapies[2].
Impact on Linezolid
Given the general trend of pharmaceutical price inflation, it is reasonable to expect that the price of Linezolid could also increase. However, the specific rate of inflation for Linezolid may vary based on market conditions, competition, and regulatory changes.
Regulatory and Market Factors
FDA Regulations
The FDA's National Drug Code Directory provides comprehensive information on drug products, including Linezolid. Any changes in FDA regulations or the approval of new indications could impact the pricing and demand for Linezolid[5].
Biopharma and Biotech Trends
The biopharma and biotech industries are experiencing rapid growth, driven by advancements in clinical trial designs, regulatory frameworks, and a shift towards personalized medicine. While these trends may not directly impact the pricing of Linezolid, they can influence the broader pharmaceutical market and indirectly affect pricing dynamics[3].
Clinical Trial and Innovation Impact
Accelerated Clinical Trials
The shift towards more innovative and efficient clinical trial designs could lead to faster approval times for new drugs, potentially increasing competition in the market. However, Linezolid's established position as an effective treatment for resistant bacterial infections is likely to maintain its market share[3].
Precision Medicine
The rise of precision medicine, which involves tailoring treatments to individual patients, may lead to more targeted therapies. While this could reduce the demand for broad-spectrum antibiotics like Linezolid in some cases, it is unlikely to significantly impact its overall market demand in the short term.
Gene Therapy and High-Cost Treatments
Emerging Therapies
The increasing number of high-cost cell and gene therapies entering the market may divert some healthcare spending away from traditional antibiotics. However, these therapies are typically used for different conditions and are unlikely to directly compete with Linezolid[4].
Conclusion
The price of Linezolid (NDC 00054-0319) is expected to follow the general trend of pharmaceutical price inflation, with a projected increase of around 3.81% in 2025. This projection is based on broader market trends and the absence of specific factors that would significantly alter the pricing of this drug.
Key Takeaways
- Current Pricing: The price per unit of Linezolid has fluctuated between $1.69 and $1.95 per ml in recent months.
- Projected Inflation: An overall pharmaceutical price inflation rate of 3.81% is expected for 2025.
- Market Demand: Steady demand driven by the need for effective treatments against antibiotic-resistant bacteria.
- Regulatory and Market Factors: FDA regulations and broader biopharma trends may indirectly influence pricing.
FAQs
What is the current price of Linezolid (NDC 00054-0319)?
As of December 2024, the price per unit of Linezolid 100 mg/5 ml suspension is approximately $1.95344 per ml[1].
What is the projected price inflation rate for pharmaceuticals in 2025?
The projected overall drug price inflation rate for 2025 is 3.81% according to Vizient's summer Pharmacy Market Outlook[2].
How does the rise of precision medicine affect the demand for Linezolid?
Precision medicine may lead to more targeted therapies, but it is unlikely to significantly reduce the demand for broad-spectrum antibiotics like Linezolid in the short term[3].
What are the key factors influencing the price of Linezolid?
Key factors include overall pharmaceutical market trends, FDA regulations, and the introduction of new high-cost therapies[2][4].
Are there any new indications or approvals that could impact the pricing of Linezolid?
There are no recent indications or approvals specifically mentioned for Linezolid that would significantly alter its pricing dynamics[5].
Sources
- DrugPatentWatch - Latest drug prices and trends for NDC 00054-0319.
- Vizient Inc. - Vizient projects drug price inflation at 3.81%.
- TFS CRO - 5 Predictions for the Biopharma and Biotech Industries in 2025.
- Vizient Inc. - Pharmacy Market Outlook Summer 2024.
- FDA - National Drug Code Directory.
